Natriuretic peptides: biomarkers for atrial fibrillation management

A Sepehri Shamloo, A Bollmann, N Dagres… - Clinical Research in …, 2020 - Springer
In clinical practice, atrial fibrillation (AF) is known as the most common sustained arrhythmia.
Therefore, identification of individuals at risk of AF development/recurrence or its associated …
被引用次数：34 相关文章

Natriuretic peptides: biomarkers for atrial fibrillation management

AS Shamloo, A Bollmann, N Dagres… - Clinical research in …, 2020 - pubmed.ncbi.nlm.nih.gov
In clinical practice, atrial fibrillation (AF) is known as the most common sustained arrhythmia.
Therefore, identification of individuals at risk of AF development/recurrence or its associated …

Natriuretic peptides: biomarkers for atrial fibrillation management

SA Sepehri, A Bollmann, D Nikolaos… - Clinical Research in …, 2020 - search.proquest.com
In clinical practice, atrial fibrillation (AF) is known as the most common sustained arrhythmia.
Therefore, identification of individuals at risk of AF development/recurrence or its associated …

Natriuretic peptides: biomarkers for atrial fibrillation management.

A Bollmann, N Dagres, G Hindricks… - Clinical Research in …, 2020 - europepmc.org
In clinical practice, atrial fibrillation (AF) is known as the most common sustained arrhythmia.
Therefore, identification of individuals at risk of AF development/recurrence or its associated …